Replies to post #250165 on Biotech Values

[DewDiligence]

ALVR lays off 95% of workforce following clinical failure in December:

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001754068/000119312524002563/d35101d8k.htm

With almost $200M of net current assets, ALVR is a good candidate for a reverse-merger.